The invention discloses a 4,6-dimethyl-oxazolo[5,4-d]
pyrimidine-5,7(4H,6H)-dione derivative acting on a
fibroblast growth factor (FGF)
receptor. A target compound is prepared by implementing
nitrosation on 1,3-dimethyl
pyrimidine-2,4,6(1H,3H,5H)-trione which serves as a starting material through NaNO2, reducing the material through Na2S2O4, implementing a Schiff alkali reaction with aromatic
aldehyde, and finally cyclizing through SOCl2. The 4,6-dimethyl-oxazolo[5,4-d]
pyrimidine-5,7(4H,6H)-dione derivative disclosed by the invention has a certain inhibiting function on experimental cells and shows a certain
antitumor activity. For an H460
cell, IC50 values of compounds N5a, N5g and N5k are less than that of a
positive control drug; for a B16F10
cell, IC50 values of compounds N5f, N5h and N5i are less than IC50 value of the
positive control drug; for an A549
cell, IC50 value of the
positive control is relatively high, and IC50 values of compounds N5f, N5g, N5h and N5l are less than IC50 value of the positive control
drug.